NEWS

  • Studying MPNs in the Lab and in Space

    Catriona Jamieson, MD, PhD, University of California, San Diego Why is it that only some people progress from polycythemia vera or essential thrombocythemia to myelofibrosis? And why do only some people with myelofibrosis progress to AML?   When Catriona Jamieson, MD, PhD, and her colleagues at University of California, San Diego, first asked these questions around… Read More »Studying MPNs in the Lab and in Space

    READ MORE

    ICYMI Webinar on Progression

    https://www.youtube.com/watch?v=yaeHpBdRxJo The science of progression was the subject of a recent webinar hosted by MPN Advocacy & Education International, in partnership with the MPN Research Foundation. The recording is now available, featuring Raajit Rampal, MD, PhD, of Memorial Sloan Kettering Cancer Center, and MPNRF Chief Executive Officer Kapila Viges. Dr. Rampal serves as the foundation’s… Read More »ICYMI Webinar on Progression

    READ MORE

    From Lab to Clinic and Back

    Yelena Ginzburg, MD, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Dr. Yelena Ginzburg’s research illustrates how basic research, clinical data, and clinical trial development inform each other in what is often a continuous loop between lab and clinic. Funded by a 2019-2021 MPN Challenge award, her work focuses on understanding why iron… Read More »From Lab to Clinic and Back

    READ MORE

    MPN Leaders Added to Scientific Advisory Board

    Our Scientific Advisory Board represents an extraordinary group of MPN thought leaders who contribute a broad range of medical, scientific, and short- and long-term strategic advice to the foundation. We greatly appreciate the commitment by all of the members of this outstanding volunteer board, and welcome five new members. • Radek Skoda, MD, PhD, University… Read More »MPN Leaders Added to Scientific Advisory Board

    READ MORE

    IMPACT@21 Report Launched

    With a 21-year history of impactful MPN research, we’re proud of where we started, where we are, and most importantly, where we’re headed. Check out our IMPACT@21 story in this new digital report, featuring the voices of leading MPN researchers, clinicians, advocates and people living with ET, PV and MF.

    READ MORE

    Voice of the Patient Report Delivered to FDA

    “One of the biggest things that has changed in my life is I’ve had to give things up. I have visual problems (it’s like a blind spot) so I really cut down on my driving. I had to quit cooking because I made so many mistakes. I’ll walk into a room looking for something and… Read More »Voice of the Patient Report Delivered to FDA

    READ MORE

    ASH 2021: Features Multiple MPNRF-Funded Projects 

    Thanks to a robust and growing MPN research community, the 63rd Annual Meeting and Exposition of the American Society of Hematology, ASH-21, was packed with illuminating MPN developments. Summarized here are a few of the exciting ASH 2021 presentations, workshops and posters by global researchers we’re proud to have funded. In addition, some of these… Read More »ASH 2021: Features Multiple MPNRF-Funded Projects 

    READ MORE

    New Year’s Note from CEO, Kapila Viges

    What’s Next? At the end of a productive meeting, day, or week, I’m always asking myself, “what’s next.” Next on my calendar, next on my list, next on the agenda. Last year, I recognized that to get to what’s next as a foundation, I first had to learn, listen, and prepare. I learned about the… Read More »New Year’s Note from CEO, Kapila Viges

    READ MORE

    Targeted Oncology Highlights Global Interferon Initiative

    In an article in Targeted Oncology entitled, “The Expanding Role of Interferons in Myeloproliferative Neoplasms,” Dr. Richard Silver, director emeritus of the Silver MPN Center at Weill Cornell Medicine, discussed the importance of our three-year global Interferon Initiative to shed light on key questions such as which patients are likely to benefit from recombinant interferon alpha and why resistance to it may develop over… Read More »Targeted Oncology Highlights Global Interferon Initiative

    READ MORE

    Global Research Impacts Patients Around the World

    Earlier this month, we joined our global partners as part of the 6th International MPN Horizons Conference, convening MPN advocates from 33 countries to share the latest research, care standards, and current therapies.  Amongst the rich medical and advocacy content presented, Kapila Viges of MPNRF co-chaired two medical sessions. The first highlighted genetic testing, disease progression,… Read More »Global Research Impacts Patients Around the World

    READ MORE

    1 2 3 4 39
  • Get updates on MPN patients and research breakthroughs.
    What are the latest developments in MPN Research?